1
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Termination of second-trimester pregnancy by laminaria and intramuscular injections of 15-methyl PGF or 16-phenoxy-ω-17, 18, 19, 20-tetranor PGE2 methyl sulfonylamide: A randomized study

&
Pages 535-537 | Received 23 Jun 1982, Published online: 09 Jul 2009

References

  • Bygdeman M. Comparison of prostaglandin and hy-pertonic saline for termination of pregnancy. Obstet Gynecol 1978; 52: 424
  • Karim S. M. M., Choo H. T., Lin A. L., Ratnam S. S. Termination of second trimester pregnancy with intramuscular administration of 16-phenoxy-ω-17,18,19,20-tetranor PGE2 methyl sulfonylamide. Pro-staglandins 1978; 15: 1063
  • Karim S. M. M., Ratnam S. S. Termination of second trimester pregnancy with laminaria and intramuscular 16-phenoxy-ω-17,18, 19,20-tetranor PGE2 methyl sulfonylamide. A randomized study. Prosta-glandins 1982; 23: 257
  • Pulkinen M. D., Kajano R., Kivikoski A., Saasta-moinen J., Selander K., Tuimana R. Abortion with sulprostone, a prostaglandin E2 derivation. In J Gynaecol Obstet 1980; 18: 40
  • Wiquist N., Bygdeman M., Toppozada M. Intra-amniotic prostaglanding administration — a challenge to the currently used methods for induction of midtri-mester abortion. Contraception 1973; 8: 113
  • WHO Task Force on Prostaglandins for Fertility Regulation: Intramuscular administration of 15-methyl prostaglandin F2α for induction of abortion in weeks 10 to 20 of pregnancy. Am J Obstet Gynecol 1977; 129: 593
  • WHO Task Force on Prostaglandins for Fertility Regulation: Comparison of intra-amniotic prostaglandin F2α and hypertonic saline for induction of second trimester abortion. Br Med J 1976; ii: 1373

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.